Delivery Order SPE2DB20D3104-SPE2DB24FV8C6
Award Date
7/10/24
Potential Completion Date
7/11/24
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,628.89 firm fixed-price delivery order is for the supply of Irbesartan 150 mg tablets, a medication used to treat high blood pressure. The contract has an ultimate completion date of November 12, 2024 and was awarded on November 8, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The delivery order, valued at $2,697.68, is for the supply of Irbesartan 150 mg tablets. The contract has a firm fixed price pricing type and an ultimate completion date of June 25, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and...
This federal contract award, identified as SPE2DB22D2007|SPE2DB25FH7JY, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Irbesartan 150 mg tablets, a cardiovascular medication, with a total ceiling value of $6,617.42 and a completion date of December 4, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Irbesartan 150 mg tablets. The $5,275.08 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and the vendor's parent company, Cencora, Inc. This IDC serves as the primary vehicle for Cencora, Inc. to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,432.74, is for the delivery of Irbesartan 300 mg tablets. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Irbesartan 300 mg tablets to the Defense Logistics Agency (DLA). The $2,564.06 firm fixed-price delivery order has a completion date of February 11, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,835.50, is for the delivery of Irbesartan 300 mg tablets. The contract is a firm fixed-price delivery order with a completion date of February 11, 2025. This award is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, valued at $3,637.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award, valued at $11,048.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Irbesartan 300 mg tablets, a medication used to treat high blood pressure. The contract is a Firm Fixed Price Delivery Order with a completion date of January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Irbesartan 150 mg tablets in quantities of 90 per bottle. The contract has a ceiling value of $2,623.10 and a completion date of December 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running...